Medicine and Dentistry
Bronchiectasis
100%
Chronic Airway Disease
85%
Disease
85%
Endotype
85%
Sputum
68%
Cystic Fibrosis
57%
Leukocyte Elastase
54%
Mucin
51%
Cytokine
45%
Chronic Obstructive Pulmonary Disease
42%
COVID-19
42%
Clinical Trial Design
42%
Dipeptidyl Peptidase
42%
Placebo
42%
Asthma
28%
Respiratory Disease
28%
Clinical Research
21%
Combination Therapy
21%
Polypeptide Antibiotic Agent
17%
Serine Proteinase
17%
Mucin 5AC
17%
Myeloperoxidase
17%
Patient with Asthma
14%
Mucus
14%
Smoking
14%
Eosinophilic
14%
Mucociliary Clearance
14%
Mucin 5B
14%
Pathogen
10%
Baricitinib
10%
Oncology
10%
Antibody Therapy
10%
Patient Population
10%
Respiratory Medicine
10%
Diseases
10%
Dexamethasone
10%
Arm
10%
Infectious Disease
10%
Interleukin 6
8%
Immunoassay
8%
Chemokine
8%
Inflammatory Cytokine
8%
Proteinase
8%
Neutrophil
8%
Enzyme Linked Immunosorbent Assay
8%
Liquid Chromatography-Mass Spectrometry
8%
Antiinflammatory Activity
8%
Clinical Trial
8%
Keyphrases
Mucociliary Dysfunction
85%
Chronic Airways Disease
85%
Cystic Fibrosis
85%
Disease Groups
64%
Mucin
64%
Bronchiectasis
64%
Disease Labels
42%
Inflammation
42%
DNA Content
42%
Asthma
42%
Sputum
42%
Neutrophil Elastase
42%
Tan delta
21%
N-group
21%
K-means Clustering
21%
E-Group
21%
Rheology Parameters
21%
E-cluster
21%
Asthma Patients
21%
Healthy Controls
21%
Non-cystic Fibrosis Bronchiectasis
21%
Spontaneous Sputum
21%
MUC5B
21%
Group Control
21%
Mucus
21%
Rheology
21%
Neutrophilic Inflammation
21%
Smokers
21%
All Diseases
21%
COPD Patients
21%
Mucociliary Clearance
21%
Respiratory Disease
21%
Airway Disease
21%
K-means
21%
Primary Disease
21%
Disease Pattern
21%
Clinical Characteristics
21%
REMAP-CAP
21%
Multiple Arms
21%
CCL8
9%
Immunology and Microbiology
Asthma
85%
Mucin
85%
Sputum
85%
Dry Weight
85%
Cytokine
57%
DNA Content
57%
Neutrophil
57%
Flow Kinetics
57%
MUC5B
28%
Mucociliary Clearance
28%
Myeloperoxidase
21%
CCL8
21%
CCL11
10%
CCL13
10%
